Multiple Myeloma Chemotherapy
Multiple myeloma chemotherapy uses drugs to kill cancerous myeloma cells in the body. Chemotherapy for multiple myeloma may involve combining drugs with biological therapy and steroids. Myeloma chemotherapy is often conducted in cycles, with some chemotherapy drugs being administered daily while some drugs are administered on a weekly basis. These chemotherapy cycles can last up to a month, and 4 to 6 cycles will usually make up one course of treatment. With all this in mind, chemotherapy can last for up to a total of 4-6 months.
Myeloma chemotherapy treatments may be administered orally or intravenously. Common chemotherapy drugs include Doxil (Lipsomal doxorubicin) or Treanda (Bendamustine). These drugs are typically part of a combined treatment that will include other drugs such as corticosteroids or immunomodulating agents. Treatments may also include stem cell transplants to restore essential cells lost from chemotherapy.